Barbara Murray, MD, 2014 president of the Infectious Diseases Society of America (IDSA), is passed the gavel by 2013 IDSA president David Relman, MD.
Barbara E. Murray, MD, professor and director of the Division of Infectious Diseases at the University of Texas Health Science Center at Houston (UTHealth) Medical School, has become the 2014 president of the Infectious Diseases Society of America (IDSA).
Murray began her term as president on Oct. 4, 2013Â at the annual meeting of the IDSA, the Society for Healthcare Epidemiology of America, the HIV Medicine Association and the Pediatric Infectious Diseases Society in San Francisco. The meeting is called IDWeek.
The IDSA has approximately 10,000 members and its purpose is to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention of infectious diseases. It was founded in 1963.
Murrays research is focused on understanding what makes antibiotic-resistant bacteria or superbugs tick and developing new treatments for them. Superbugs threaten to reverse advances made by infectious disease researchers in the last century
Herbert DuPont, MD, holder of the Mary W. Kelsey Distinguished Chair in the Medical Sciences and director of the Center for Infectious Diseases at The University of Texas School of Public Health, a part of UTHealth, described Murray as a national leader on antibiotic resistance and microbiology, and the importance of enterococci as human pathogens.
DuPont, a past IDSA president, added that Murray as IDSA president has the opportunity to help lead the country in important areas designed to control emerging infectious diseases and reduce the enormous burden of antibiotic resistance.
As a child, Murray experienced the effect of infectious disease firsthand. At the age of 4, she was hospitalized for polio. Later as a medical student, she traveled to Costa Rica, Guatemala and Colombia, where she saw that clinicians spent a considerable amount of their time treating transmissible diseases.
Murray graduated with a degree in mathematics cum laude from Rice University in 1969 and was first in her graduating class from UT Southwestern Medical Center in Dallas in 1973. She spent six years training in internal medicine and infectious diseases at Harvard Medical School and Massachusetts General Hospital. She later spent six months at the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand.
Murray joined the UTHealth Medical School faculty in 1980 and is now the director of the Center for the Study of Emerging and Re-emerging Pathogens and holder of the J. Ralph Meadows Professorship in Internal Medicine. She has been the director of the Infectious Diseases Division since 1995.
Murray, whose research receives support from the National Institutes of Health, has approximately 300 peer-reviewed publications. She writes for Harrison's Principles of Internal Medicine, the online text UpToDate, and Mandell, Douglas and Bennett's Textbook of Infectious Diseases. She also has written reviews for The New England Journal of Medicine and Nature Reviews in Microbiology.
Source: University of Texas Health Science Center at Houston
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.